{{Rsnum
|rsid=17612648
|Gene=PTPRC
|Chromosome=1
|position=198696788
|Orientation=plus
|GMAF=0.007346
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=PTPRC
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 95.2 | 4.8 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19879912
|Title=No association between transmembrane protein-tyrosine-phosphatase receptor type C (CD45) exon A 77C&gt;G transversion and Hashimoto's thyroiditis in a German population
}}
{{PMID Auto
|PMID=21067564
|Title=The CD45 77C/G allele is not associated with myasthenia gravis - a reassessment of the potential role of CD45 in autoimmunity
|OA=1
}}

{{PMID|16400609|OA=1
}} Single-nucleotide polymorphisms in NAGNAG acceptors are highly predictive for variations of alternative splicing.

{{PMID|18634151}} No association between systemic sclerosis and C77G polymorphism in the human PTPRC (CD45) gene.

{{PMID|20158892|OA=1
}} Genomic features defining exonic variants that modulate splicing.

{{PMID|22524693}} No association between transmembrane protein-tyrosine phosphatase receptor type C (PTPRC) exon A 77C>G transversion and liver transplant rejection.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}